E-mail

E-mail a Wiley Online Library Link

K. Kontou-Fili and C. I. Filis Prolonged high-dose omalizumab is required to control reactions to venom immunotherapy in mastocytosis Allergy 64

Version of Record online: 29 APR 2009 | DOI: 10.1111/j.1398-9995.2009.02045.x

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH